Early Intervention Coping Kids (TIM) Follow up Study

NCT05766072 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 217

Last updated 2026-05-13

No results posted yet for this study

Summary

The project objectives are to investigate if a preventive intervention targeting anxious and sad children aged 8 to 12 years has haf the anticipated long-term effects, 5 years after receiving the intervention. Hence: will an indicated intervention reduce the incidence of common mental disorders in youth in the long term? The current study is a 5 year follow up of the previously completed RCT called the TIM-study (Clinical Trials identifier: NCT 02340637).

The aim of this study is to determine the long-term effects of the intervention to examine if true preventive effects are achieved as indicated by lower symptom levels, better functioning og fewer diagnosis of anxiety and depression 5 years after receiving an indicated preventiv intervention.

Conditions

Interventions

OTHER

EMOTION Kids coping with anxiety and depression (Mestrende barn in Norwegian)

The intervention is transdiagnostic and based on cognitive behavioral therapy where the children and their parents meet i groups led of school health nurses. They are learning coping skills to meet challenging and avoided situations, learning about emotion regulation, physical symptoms conitive restructuring and exposure/behavioral activation. Te manual is publshed in a US/English version and in a Norwegian version.

Sponsors & Collaborators

  • The Dam Foundation

    collaborator OTHER
  • University of Oslo

    lead OTHER

Principal Investigators

  • Jo Magne Ingul, PhD · Regional Centre for Child and Youth Mental Health and Child Welfare (RKBU), Trondheim, Norway

  • Frode Adolfsen, PhD · Regional Centre for Child and Youth Mental Health and Child Welfare North, UiT, Tromsø, Norway

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-13
Primary Completion
2024-02-29
Completion
2024-04-01

Countries

  • Norway

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05766072 on ClinicalTrials.gov